Clinical Trial Update: Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term safety and efficacy data for budesonide inhalation suspension in Japanese children with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide Inhalation Suspension (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED